1. Home
  2. MYSZ vs HCWB Comparison

MYSZ vs HCWB Comparison

Compare MYSZ & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

N/A

Current Price

$0.52

Market Cap

2.5M

Sector

Technology

ML Signal

N/A

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.04

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
HCWB
Founded
1999
2018
Country
Israel
United States
Employees
45
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
3.0M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MYSZ
HCWB
Price
$0.52
$1.04
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
24.3K
13.7M
Earning Date
04-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
57.40
N/A
EPS
N/A
N/A
Revenue
$142,000.00
$4,099,750.00
Revenue This Year
$41.64
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
125.40
N/A
52 Week Low
$0.50
$0.25
52 Week High
$1.65
$8.75

Technical Indicators

Market Signals
Indicator
MYSZ
HCWB
Relative Strength Index (RSI) 32.69 66.67
Support Level N/A $0.37
Resistance Level $0.68 $1.26
Average True Range (ATR) 0.04 0.14
MACD -0.01 0.10
Stochastic Oscillator 8.60 55.38

Price Performance

Historical Comparison
MYSZ
HCWB

About MYSZ My Size Inc.

My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: